Secukinumab in the treatment of psoriatic arthritis: efficacy and safety results through 3 years from the year 1 extension of the randomised phase III FUTURE 1 trial

Philip J. Mease*, Arthur Kavanaugh, Andreas Reimold, Hasan Tahir, Juergen Rech, Stephen Hall, Piet Geusens, Pascale Pellet, Evie Maria Delicha, Shephard Mpofu, Luminita Pricop, FUTURE 1 Study Grp

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

26 Citations (Web of Science)
Original languageEnglish
Article numbere000723
Pages (from-to)1-9
Number of pages9
JournalRMD Open
Volume4
Issue number2
DOIs
Publication statusPublished - 1 Jul 2018

Keywords

  • ANTI-INTERLEUKIN-17A MONOCLONAL-ANTIBODY
  • ANKYLOSING-SPONDYLITIS
  • DOUBLE-BLIND
  • PHARMACOLOGICAL THERAPIES
  • TREATMENT RECOMMENDATIONS
  • RHEUMATOID-ARTHRITIS
  • JOINT INFLAMMATION
  • CLINICAL-RESPONSE
  • EUROPEAN LEAGUE
  • BONE EROSION

Cite this